HYPERION DEFI, INC. Deferred Tax Assets, Net of Valuation Allowance
HYPERION DEFI, INC. (HYPD) had Deferred Tax Assets, Net of Valuation Allowance of $89.41 thousand as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Net of Valuation Allowance $89.41K.
- 2024-12-31: Deferred Tax Assets, Net of Valuation Allowance $245.57K.
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $698.48K.
- 2018-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2025-12-31 | $89.41K 10-K · filed 2026-03-30 |
| 2024-12-31 | $245.57K 10-K · filed 2026-03-30 |
| 2023-12-31 | $698.48K 10-K · filed 2025-04-15 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-30 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-27 |
| 2016-12-31 | $0.00 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |